- Home
- EQR vs ZBH Comparison
EQR vs ZBH Comparison
Compare EQR & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQR
- ZBH
- Stock Information
- Founded
- EQR 1993
- ZBH 1927
- Country
- EQR United States
- ZBH United States
- Employees
- EQR N/A
- ZBH N/A
- Industry
- EQR Real Estate Investment Trusts
- ZBH Industrial Specialties
- Sector
- EQR Real Estate
- ZBH Health Care
- Exchange
- EQR Nasdaq
- ZBH Nasdaq
- Market Cap
- EQR 24.5B
- ZBH 19.9B
- IPO Year
- EQR 1993
- ZBH N/A
- Fundamental
- Price
- EQR $59.00
- ZBH $88.44
- Analyst Decision
- EQR Buy
- ZBH Buy
- Analyst Count
- EQR 11
- ZBH 19
- Target Price
- EQR $72.68
- ZBH $110.56
- AVG Volume (30 Days)
- EQR 3.0M
- ZBH 1.9M
- Earning Date
- EQR 10-28-2025
- ZBH 11-05-2025
- Dividend Yield
- EQR 4.63%
- ZBH 1.10%
- EPS Growth
- EQR 24.49
- ZBH N/A
- EPS
- EQR 3.03
- ZBH 4.03
- Revenue
- EQR $3,078,827,000.00
- ZBH $8,010,900,000.00
- Revenue This Year
- EQR $5.00
- ZBH $8.20
- Revenue Next Year
- EQR $3.68
- ZBH $5.92
- P/E Ratio
- EQR $19.70
- ZBH $21.71
- Revenue Growth
- EQR 4.69
- ZBH 5.47
- 52 Week Low
- EQR $58.38
- ZBH $85.84
- 52 Week High
- EQR $78.32
- ZBH $114.72
- Technical
- Relative Strength Index (RSI)
- EQR 35.18
- ZBH 31.05
- Support Level
- EQR $58.38
- ZBH $97.89
- Resistance Level
- EQR $59.92
- ZBH $103.69
- Average True Range (ATR)
- EQR 1.29
- ZBH 2.74
- MACD
- EQR -0.24
- ZBH -1.31
- Stochastic Oscillator
- EQR 11.06
- ZBH 14.43
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.